Calorie Restriction Increases the Number of Competing Stem Cells and Decreases Mutation Retention in the Intestine by Bruens, Lotte, Ellenbroek, Saskia Inge Johanna, Suijkerbuijk, Saskia Jacoba Elisabeth, Azkanaz, Maria, Hale, Alexander James, Toonen, Pim, Flanagan, Dustin James, Sansom, Owen James, Snippert, Hugo Johannes, van Rheenen, Jacco

Get full text

Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses by de Witte, Chris Jenske, Espejo Valle-Inclan, Jose, Hami, Nizar, Lõhmussaar, Kadi, Kopper, Oded, Vreuls, Celien Philomena Henrieke, Jonges, Geertruida Nellie, van Diest, Paul, Nguyen, Luan, Clevers, Hans, Kloosterman, Wigard Pieter, Cuppen, Edwin, Snippert, Hugo Johannes Gerhardus, Zweemer, Ronald Peter, Witteveen, Petronella Oda, Stelloo, Ellen

Get full text

Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancer by Mertens, Sander, Huismans, Maarten A., Verissimo, Carla S., Ponsioen, Bas, Overmeer, Rene, Proost, Natalie, van Tellingen, Olaf, van de Ven, Marieke, Begthel, Harry, Boj, Sylvia F., Clevers, Hans, Roodhart, Jeanine M.L., Bos, Johannes L., Snippert, Hugo J.G.

Get full text

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening by Verissimo, Carla S, Overmeer, René M, Ponsioen, Bas, Drost, Jarno, Mertens, Sander, Verlaan-Klink, Ingrid, Gerwen, Bastiaan van, van der Ven, Marieke, Wetering, Marc van de, Egan, David A, Bernards, René, Clevers, Hans, Bos, Johannes L, Snippert, Hugo J

Get full text

CRISPR-induced RASGAP deficiencies in colorectal cancer organoids reveal that only loss of NF1 promotes resistance to EGFR inhibition by Post, Jasmin B, Hami, Nizar, Mertens, Alexander E E, Elfrink, Suraya, Bos, Johannes L, Snippert, Hugo J G

Get full text